Lipid abnormalities during ART: it's the drug, not the class

A Comparison of Self-reported Pain Measures Between Sensory Phenotypes in HIV-associated Sensory Neuropathy.

The journal of pain·2022

A randomized comparative trial of continued abacavir/lamivudine plus efavirenz or replacement with efavirenz/emtricitabine/tenofovir DF in hypercholesterolemic HIV-1 infected individuals.

PloS one·2015

Changes in bone mineral density after 96 weeks of treatment with atazanavir/ritonavir or lopinavir/ritonavir plus tenofovir DF/emtricitabine in treatment-naive patients with HIV-1 infection: the CASTLE body composition substudy.

Journal of acquired immune deficiency syndromes (1999)·2014

Comparison of body composition changes between atazanavir/ritonavir and lopinavir/ritonavir each in combination with tenofovir/emtricitabine in antiretroviral-naïve patients with HIV-1 infection.

Clinical drug investigation·2014

96-Week results of abacavir/lamivudine versus tenofovir/emtricitabine, plus efavirenz, in antiretroviral-naive, HIV-1-infected adults: ASSERT study.

Antiviral therapy·2013

A randomized comparative 96-week trial of boosted atazanavir versus continued boosted protease inhibitor in HIV-1 patients with abdominal adiposity.

Antiviral therapy·2012

Effect of antiretroviral resistance on response in treatment-experienced patients.

The AIDS reader·2009

Maximizing treatment outcome: key considerations for antiretroviral-experienced patients.

The AIDS reader·2009

Utilizing a new class of antiretrovirals: role of fusion inhibitors in HIV disease management.

The AIDS reader·2009

Acute renal failure in patients with AIDS on tenofovir while receiving prolonged vancomycin course for osteomyelitis.

The AIDS reader·2009

Isolated unilateral acute retinal necrosis syndrome as the initial manifestation of HIV infection.

The AIDS reader·2009

Colitis and gastroparesis associated with syphilis in an HIV-infected person with an undetectable viral load.

The AIDS reader·2009

Black Elderberry Exposure in Apparent Idiopathic Mild Acute Pancreatitis: A Case Report.

Cureus·2026

Suspected levetiracetam drug-induced lupus in a child: A case report.

SAGE open medical case reports·2026

An ETH-LAD trip with unfavourable consequences: A case report.

British journal of clinical pharmacology·2026

Retraction Note: An insight into the sequential, structural and phylogenetic properties of banana 1-aminocyclopropane-1-carboxylate synthase 1 and study of its interaction with pyridoxal-5'-phosphate and aminoethoxyvinylglycine.

Journal of genetics·2026

RETRACTED: Paladugu et al. Liraglutide Has Anti-Inflammatory and Anti-Amyloid Properties in Streptozotocin-Induced and 5xFAD Mouse Models of Alzheimer's Disease. Int. J. Mol. Sci. 2021, 22, 860.

International journal of molecular sciences·2026

Co-Occurrence of En Coup de Sabre, Parry-Romberg Syndrome, and Hemimasticatory Spasm: A Case Report.

Case reports in dermatology·2026

Related Experiment Videos

Lipid abnormalities during ART: it's the drug, not the class

Related Concept Videos

A Comparison of Self-reported Pain Measures Between Sensory Phenotypes in HIV-associated Sensory Neuropathy.

A randomized comparative trial of continued abacavir/lamivudine plus efavirenz or replacement with efavirenz/emtricitabine/tenofovir DF in hypercholesterolemic HIV-1 infected individuals.

Changes in bone mineral density after 96 weeks of treatment with atazanavir/ritonavir or lopinavir/ritonavir plus tenofovir DF/emtricitabine in treatment-naive patients with HIV-1 infection: the CASTLE body composition substudy.

Comparison of body composition changes between atazanavir/ritonavir and lopinavir/ritonavir each in combination with tenofovir/emtricitabine in antiretroviral-naïve patients with HIV-1 infection.

96-Week results of abacavir/lamivudine versus tenofovir/emtricitabine, plus efavirenz, in antiretroviral-naive, HIV-1-infected adults: ASSERT study.

A randomized comparative 96-week trial of boosted atazanavir versus continued boosted protease inhibitor in HIV-1 patients with abdominal adiposity.

Effect of antiretroviral resistance on response in treatment-experienced patients.

Maximizing treatment outcome: key considerations for antiretroviral-experienced patients.

Utilizing a new class of antiretrovirals: role of fusion inhibitors in HIV disease management.

Acute renal failure in patients with AIDS on tenofovir while receiving prolonged vancomycin course for osteomyelitis.

Isolated unilateral acute retinal necrosis syndrome as the initial manifestation of HIV infection.

Colitis and gastroparesis associated with syphilis in an HIV-infected person with an undetectable viral load.

Black Elderberry Exposure in Apparent Idiopathic Mild Acute Pancreatitis: A Case Report.

Suspected levetiracetam drug-induced lupus in a child: A case report.

An ETH-LAD trip with unfavourable consequences: A case report.

Retraction Note: An insight into the sequential, structural and phylogenetic properties of banana 1-aminocyclopropane-1-carboxylate synthase 1 and study of its interaction with pyridoxal-5'-phosphate and aminoethoxyvinylglycine.

RETRACTED: Paladugu et al. Liraglutide Has Anti-Inflammatory and Anti-Amyloid Properties in Streptozotocin-Induced and 5xFAD Mouse Models of Alzheimer's Disease. Int. J. Mol. Sci. 2021, 22, 860.

Co-Occurrence of En Coup de Sabre, Parry-Romberg Syndrome, and Hemimasticatory Spasm: A Case Report.

Related Experiment Videos

Lipid abnormalities during ART: it's the drug, not the class

Related Concept Videos

Related Articles